As of 2024-09-14, the Relative Valuation of BioLife Solutions Inc (BLFS) is (26.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.12 USD, the upside of BioLife Solutions Inc based on Relative Valuation is -206.2%.
The range of the Relative Valuation is (27.38) - (27.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 17.1x | 16.1x |
| Forward P/E multiples | 17.2x - 17.6x | 17.4x |
| Fair Price | (27.38) - (27.22) | (26.66) |
| Upside | -209.0% - -208.4% | -206.2% |
| Date | P/E |
| 2024-09-13 | -15.78 |
| 2024-09-12 | -15.25 |
| 2024-09-11 | -14.57 |
| 2024-09-10 | -14.89 |
| 2024-09-09 | -14.52 |
| 2024-09-06 | -14.94 |
| 2024-09-05 | -15.53 |
| 2024-09-04 | -15.50 |
| 2024-09-03 | -15.35 |
| 2024-08-30 | -16.26 |
| 2024-08-29 | -16.28 |
| 2024-08-28 | -15.92 |
| 2024-08-27 | -16.24 |
| 2024-08-26 | -16.32 |
| 2024-08-23 | -15.89 |
| 2024-08-22 | -15.36 |
| 2024-08-21 | -16.16 |
| 2024-08-20 | -16.06 |
| 2024-08-19 | -16.60 |
| 2024-08-16 | -16.24 |
| 2024-08-15 | -16.18 |
| 2024-08-14 | -16.27 |
| 2024-08-13 | -16.66 |
| 2024-08-12 | -16.21 |
| 2024-08-09 | -15.86 |
| 2024-08-08 | -14.28 |
| 2024-08-07 | -13.85 |
| 2024-08-06 | -14.37 |
| 2024-08-05 | -13.88 |
| 2024-08-02 | -14.23 |
| 2024-08-01 | -14.67 |
| 2024-07-31 | -15.09 |
| 2024-07-30 | -15.10 |
| 2024-07-29 | -14.95 |
| 2024-07-26 | -15.10 |
| 2024-07-25 | -14.47 |
| 2024-07-24 | -14.04 |
| 2024-07-23 | -14.30 |
| 2024-07-22 | -13.62 |
| 2024-07-19 | -13.20 |
| 2024-07-18 | -13.47 |
| 2024-07-17 | -14.14 |
| 2024-07-16 | -14.30 |
| 2024-07-15 | -13.07 |
| 2024-07-12 | -13.02 |
| 2024-07-11 | -13.17 |
| 2024-07-10 | -12.13 |
| 2024-07-09 | -12.05 |
| 2024-07-08 | -12.85 |
| 2024-07-05 | -12.56 |